- Home
- SMTI vs JCE Comparison
SMTI vs JCE Comparison
Compare SMTI & JCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- JCE
- Stock Information
- Founded
- SMTI 1982
- JCE 2007
- Country
- SMTI United States
- JCE United States
- Employees
- SMTI N/A
- JCE N/A
- Industry
- SMTI Medical/Dental Instruments
- JCE Trusts Except Educational Religious and Charitable
- Sector
- SMTI Health Care
- JCE Finance
- Exchange
- SMTI Nasdaq
- JCE Nasdaq
- Market Cap
- SMTI 288.2M
- JCE 249.7M
- IPO Year
- SMTI N/A
- JCE N/A
- Fundamental
- Price
- SMTI $33.01
- JCE $15.40
- Analyst Decision
- SMTI Buy
- JCE
- Analyst Count
- SMTI 1
- JCE 0
- Target Price
- SMTI $44.00
- JCE N/A
- AVG Volume (30 Days)
- SMTI 36.4K
- JCE 49.7K
- Earning Date
- SMTI 11-12-2024
- JCE 01-01-0001
- Dividend Yield
- SMTI N/A
- JCE 9.26%
- EPS Growth
- SMTI N/A
- JCE N/A
- EPS
- SMTI N/A
- JCE N/A
- Revenue
- SMTI $78,056,873.00
- JCE N/A
- Revenue This Year
- SMTI $29.95
- JCE N/A
- Revenue Next Year
- SMTI $19.68
- JCE N/A
- P/E Ratio
- SMTI N/A
- JCE N/A
- Revenue Growth
- SMTI 24.66
- JCE N/A
- 52 Week Low
- SMTI $26.00
- JCE $11.64
- 52 Week High
- SMTI $43.25
- JCE $14.28
- Technical
- Relative Strength Index (RSI)
- SMTI 34.95
- JCE 32.12
- Support Level
- SMTI $31.13
- JCE $15.27
- Resistance Level
- SMTI $34.22
- JCE $16.28
- Average True Range (ATR)
- SMTI 1.80
- JCE 0.30
- MACD
- SMTI -0.63
- JCE -0.10
- Stochastic Oscillator
- SMTI 12.98
- JCE 0.00
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest
Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities (the Options Strategy).